Discover 1,398 paid clinical trials in Sarasota, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,398
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis
Location: Bradenton FL, Clearwater FL, Tampa FL, Naples FL,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07299019
Phase3, Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
for
Multiple Sclerosis (MS) Primary Progressive
Location: Bradenton FL, Tampa FL, Maitland FL, Greenville SC,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07067463
Phase3, Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Bradenton FL, Temple Terrace FL, Winter Park FL,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase2, Phase3, Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: Bradenton FL, Bay Pines FL, Orlando FL, Sanford FL,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for
Immunoglobulin A Nephropathy (IgAN)
Location: Bradenton FL, Orlando FL, Port Saint Lucie FL,
Sponsor: Biogen
Sex: All
Age: 18+
Code: NCT06935357
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
for
Fibrostenotic Crohn's Disease
Location: Bradenton FL, Georgetown TX, Fort Worth TX,
Sponsor: Agomab Spain S.L.U.
Sex: All
Age: 18+
Code: NCT07683325
Phase2, Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Bradenton FL, Tamarac FL, Miami Lakes FL, Mobile AL,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase2, Recruiting
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
for
Heart Failure With Reduced Ejection Fraction
Location: Bradenton FL, Inverness FL, Winter Park FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07465653
Phase1, Recruiting
Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19
Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
for
Primary Biliary Cholangitis
Location: Lakewood Rch FL
Sponsor: Zydus Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT07424677
Phase3, Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Bradenton FL, Brandon FL, Tampa FL, The Villages FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06959095
Phase3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
for
Cataract
Location: Venice FL, Racine WI
Sponsor: Inder Paul Singh, M.D.
Sex: All
Age: 18+
Code: NCT06681688
Phase1, Phase2, Recruiting
Lay-Delivered Behavioral Activation in Senior Centers
for
Depression
Location: Ruskin FL, Gibsonton FL, Tampa FL, Brandon FL,
Sponsor: University of Washington
Sex: All
Age: 60+
Code: NCT04621877
Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)